Granata Bio
MA - DuxburyBiotechnology
Focus: Granata Bio is a biotechnology company focused on fertility treatments and women's health, operating a legacy contraceptive portfolio alongside Phase 3 infertility assets. Founded in 2018 and based in Duxbury, MA, the company operates as a specialized biotech in a niche but clinically important therapeutic area.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Granata Bio
AI assessmentNot HiringNo open roles listed right now. Follow Granata Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
ANDA-approved legacy asset generating cash flow to fund pipeline development in fertility space.
Products & Portfolio (1)
Help build intelligence for Granata Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.